Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06869343 · ClinicalTrials.gov registry record · NA
Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
A NA study of Orthopedic Disorder and Shoulder Arthroplasty, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06869343 is a NA study of Orthopedic Disorder and Shoulder Arthroplasty that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 10 participants, below the 134-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06869343, a NA study of Orthopedic Disorder and Shoulder Arthroplasty, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Proximal humerus fractures can be a debilitating injury in the elderly, impacting the ability to function independently or complete activities of daily living due to pain and restricted shoulder motion. Evidence has shown that reverse total shoulder arthroplasty (rTSA) is an effective option to improve pain and function for patients with acute displaced proximal humerus fractures. Given that patients undergoing rTSA for proximal humerus fractures typically experience worse functional outcomes, worse patient-reported outcomes, and higher rates of complication compared to those with elective indications for surgical intervention, it is critical to determine a secure path to recovery for these patients after surgery. Early rehabilitation has been proposed to be safe and effective for patients who undergo rTSA for elective indications; however, there is a paucity of research evaluating safety and effectiveness of timing of rehabilitation for rTSA patients in the trauma setting. Currently, there exists a great variability in postoperative rehabilitation protocols across orthopaedic practices. This study's objective is to determine the safety and effectiveness of early postoperative rehabilitation on the outcomes and postoperative complications of patients undergoing rTSA for proximal humerus fractures in order to provide more specific recommendations for this patient population.
Conditions Studied
Interventions
- OTHER Physical Therapy
Study Locations (1)
Virginia
- University of Virginia Medical Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06869343
The ClinicalTrials.gov registry entry for NCT06869343 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 134-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (93% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Orthopedic Disorder appearing as the primary indexed condition, and to 1 intervention - of which Physical Therapy is the first listed.
NCT06869343 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06869343 about?
NCT06869343 is a clinical study titled "Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture". Proximal humerus fractures can be a debilitating injury in the elderly, impacting the ability to function independently or complete activities of daily living due to pain and restricted shoulder motion. Evidence has shown that reverse total shoulder arthroplasty (rTSA) is an effective option to impr...
What is the current status of trial NCT06869343?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-05-19. Estimated completion is 2026-10-31.
What conditions does trial NCT06869343 study?
This clinical trial studies the following conditions: Orthopedic Disorder, Shoulder Arthroplasty, Humerus Fracture, Reverse Shoulder Replacement.
What interventions are being tested in trial NCT06869343?
The interventions under investigation include: Physical Therapy (OTHER).
Who is sponsoring clinical trial NCT06869343?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06869343 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Orthopedic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCT
RECRUITING · NA
-
Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain
RECRUITING · NA
-
Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery
RECRUITING · NA
-
An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA
RECRUITING · NA
-
The Impact of a mHealth Application on Outpatient Physical Therapy HEP Adherence and Outcomes: A RCT
COMPLETED · NA
-
Virtual Phone Visits Compared to In-Person Physical Visits for Post-Operative Follow-Up at a Sports Medicine Clinic
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.